Poliomyelitis Clinical Trials

14 recruiting

Poliomyelitis Trials at a Glance

9 actively recruiting trials for poliomyelitis are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Phase 2 with 5 trials, with the heaviest enrollment activity in Dublin, Dhaka, and Iloilo City. Lead sponsors running poliomyelitis studies include PATH, Sinovac Biotech Co., Ltd, and University of Dublin, Trinity College.

Browse poliomyelitis trials by phase

About Poliomyelitis Clinical Trials

Looking for clinical trials for Poliomyelitis? There are currently 14 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Poliomyelitis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Poliomyelitis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Phase 4

Phase IV Clinical Study of Sequential Vaccination of Sabin Strain and Wild Strain Inactivated Poliovirus Vaccine

Poliomyelitis
Sinovac Biotech Co., Ltd480 enrolled3 locationsNCT07457060
Recruiting
Phase 4

Phase IV Clinical Study of sIPV Administration in Adolescent and Adult Populations

Poliomyelitis
Sinovac Biotech Co., Ltd180 enrolled3 locationsNCT07354269
Recruiting
Phase 2

Study of a Novel Type 1 Oral Poliomyelitis Vaccine in Bangladesh

Poliomyelitis
PATH2,232 enrolled1 locationNCT05644184
Recruiting
Phase 2

Study of Co-administered (Types 1 & 2) Novel Oral Poliomyelitis Vaccines Evaluation

Poliomyelitis
PATH675 enrolled3 locationsNCT06895486
Recruiting
Phase 1Phase 2

A Study to Evaluate the Safety and Immunogenicity of VLP-Polio in Infants and Toddlers

Poliomyelitis
CanSino Biologics Inc.480 enrolled1 locationNCT06577298
Recruiting
Phase 2Phase 3

A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series

DiphtheriaPoliomyelitisHepatitis B+3 more
LG Chem1,186 enrolled1 locationNCT06947499
Recruiting
Phase 1Phase 2

Study of Trivalent and Bivalent (Types 1 & 2) Novel Oral Poliomyelitis Vaccines

Poliomyelitis
PATH2,400 enrolled2 locationsNCT06137664
Recruiting

Non-invasive Spinal, Cortical, and Sensorimotor Biomarkers in Motor Neurone Disease

Multiple SclerosisPrimary Lateral SclerosisMotor Neuron Disease / Amyotrophic Lateral Sclerosis+2 more
University of Dublin, Trinity College240 enrolled1 locationNCT06320444
Recruiting

Impairments of Neuro-muscular Communication in Motor-Neuron Disease: A Bio-Marker for Early and Personalised Diagnosis

Spinal Muscular AtrophyALS (Amyotrophic Lateral Sclerosis)Postpoliomyelitis Syndrome
University of Dublin, Trinity College400 enrolled1 locationNCT05663008